Christopher Clinton Conway, CEO of the Dr. Susan Love Foundation for Breast Cancer Research, made the following post on LinkedIn:
“Tower Cancer Research Foundation and Duke University Health System partner to launch first study for the Tower Cancer Research Collective!
If you are a black woman, diagnosed with breast cancer, or a genetic predisposition (i.e. BRCA gene), and have considered breast reconstruction after mastectomy, you may qualify to participate.
Please visit, https://bit.ly/tccstudies, for more information.”